{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:42:26Z","timestamp":1793418146824,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe actual cardiovascular events over a decade in patients with diffuse idiopathic skeletal hyperostosis (DISH), without previously known CV diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The medical records of patients with DISH and controls, beginning in 2006 (without known CV disease), were reviewed. Demographic, constitutional, and laboratory data were collected. Comparison of CV events following 2006 was performed according to the outcome definitions set by the Framingham score 2: coronary event demonstrated by a coronary imaging modality, acute myocardial infarction (MI), coronary death, congestive heart failure with a reduced ejection fraction, and angina pectoris.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data were available for 45 patients with DISH and 47 controls without DISH from the original cohort (91.8% and 97.9% respectively). By the Framingham score, 28.6% (\u00b1\u200920.33) of the DISH patients were expected to be affected with CVD at 10\u2009years of follow-up. We observed that nearly 39% of them developed CVD during that period (95% CI 23.8\u201353.5%). The incidence of MI over the 10-year period was significantly higher in the DISH group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005). The DISH group had higher morbidity with a higher composite outcome of 38.8% vs 25.5% in the control cohort, and the number of non-elective hospital admissions per patient, despite neither reaching statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study showed that the Framingham score underestimates the real risk for developing CVD in patients with DISH, specifically the risk for MI. We propose more scrutiny is warranted in evaluating CV risk in these patients, more demanding treatment target goals should be established, and earlier and more aggressive medical interventions should be undertaken, particularly primary prevention. Larger prospective studies are needed to corroborate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02278-w","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T06:03:15Z","timestamp":1597644195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cardiovascular disease in diffuse idiopathic skeletal hyperostosis (DISH): from theory to reality\u2014a 10-year follow-up study"],"prefix":"10.1186","volume":"22","author":[{"given":"Karina","family":"Glick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Novofastovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7904-8506","authenticated-orcid":false,"given":"Reuven","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"2278_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/030097402320318422","volume":"31","author":"C Kiss","year":"2002","unstructured":"Kiss C, O'Neill TW, Mituszova M, Szilagyi M, Poor G. The prevalence of diffuse idiopathic skeletal hyperostosis in a population-based study in Hungary. Scand J Rheumatol. 2002;31:226\u20139.","journal-title":"Scand J Rheumatol"},{"key":"2278_CR2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/rheumatology\/kep308","volume":"48","author":"R Mader","year":"2009","unstructured":"Mader R, Sarzi-Puttini P, Atzeni F, Olivieri I, Pappone N, Verlaan JJ, Buskila D. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology. 2009;48:1478\u201381.","journal-title":"Rheumatology"},{"key":"2278_CR3","first-page":"506","volume":"5","author":"R Mader","year":"2003","unstructured":"Mader R. Diffuse idiopathic skeletal hyperostosis: a distinct clinical entity. Isr Med Assoc J. 2003;5:506\u20138.","journal-title":"Isr Med Assoc J"},{"key":"2278_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/1874312901408010116","volume":"8","author":"S Pillai","year":"2014","unstructured":"Pillai S, Littlejohn G. Metabolic factors in diffuse idiopathic skeletal hyperostosis - a review of clinical data. Open Rheumatol J. 2014;8:116\u201328.","journal-title":"Open Rheumatol J"},{"key":"2278_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF02031611","volume":"4","author":"GO Littlejohn","year":"1985","unstructured":"Littlejohn GO. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin Rheumatol. 1985;4:294\u2013300.","journal-title":"Clin Rheumatol"},{"key":"2278_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.30.6.605","volume":"30","author":"H Julkunen","year":"1971","unstructured":"Julkunen H, Heinonen OP, Pyorala K. Hyperostosis of the spine in an adult population. Its relation to hyperglycaemia and obesity. Ann Rheum Dis. 1971;30:605\u201312.","journal-title":"Ann Rheum Dis"},{"key":"2278_CR7","first-page":"672","volume":"23","author":"G Vezyroglou","year":"1996","unstructured":"Vezyroglou G, Mitropoulos A, Antoniadis C. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol. 1996;23:672\u20136.","journal-title":"J Rheumatol"},{"key":"2278_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2106\/00004623-200110000-00013","volume":"83-a","author":"T Akune","year":"2001","unstructured":"Akune T, Ogata N, Seichi A, Ohnishi I, Nakamura K, Kawaguchi H. Insulin secretory response is positively associated with the extent of ossification of the posterior longitudinal ligament of the spine. J Bone Joint Surg Am. 2001;83-a:1537\u201344.","journal-title":"J Bone Joint Surg Am"},{"key":"2278_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.semarthrit.2008.01.010","volume":"38","author":"R Mader","year":"2009","unstructured":"Mader R, Novofestovski I, Adawi M, Lavi I. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum. 2009;38:361\u20135.","journal-title":"Semin Arthritis Rheum"},{"key":"2278_CR10","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"2278_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino Sr","year":"2008","unstructured":"D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743\u201353.","journal-title":"Circulation"},{"key":"2278_CR12","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1001\/archinte.165.22.2644","volume":"165","author":"SG Wannamethee","year":"2005","unstructured":"Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644\u201350.","journal-title":"Arch Intern Med"},{"key":"2278_CR13","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23:2109\u201323.","journal-title":"Stat Med."},{"key":"2278_CR14","doi-asserted-by":"crossref","unstructured":"Harari G, Green MS, Zelber-Sagi S. Estimation and development of 10- and 20-year cardiovascular mortality risk models in an industrial male workers database. Prev Med. 2017;103:26-32.","DOI":"10.1016\/j.ypmed.2017.07.012"},{"key":"2278_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/rheumatology\/41.1.27","volume":"41","author":"C Kiss","year":"2002","unstructured":"Kiss C, Szilagyi M, Paksy A, Poor G. Risk factors for diffuse idiopathic skeletal hyperostosis: a case control study. Rheumatology (Oxford). 2002;41:27\u201330.","journal-title":"Rheumatology (Oxford)"},{"key":"2278_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.joca.2008.12.004","volume":"17","author":"R Mader","year":"2009","unstructured":"Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Osteoarthr Cartil. 2009;17:825\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"2278_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/acr.21742","volume":"64","author":"C Zincarelli","year":"2012","unstructured":"Zincarelli C, Iervolino S, Di Minno MND, Miniero E, Rengo C, Di Gioia L, Vitale D, Nicolino A, Furgi G, Pappone N. Diffuse idiopathic skeletal hyperostosis prevalence in subjects affected by severe atherosclerotic cardiovascular diseases. Arthritis Care Res. 2012;64:1765\u20139.","journal-title":"Arthritis Care Res"},{"key":"2278_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1302\/0301-620X.100B5.BJJ-2017-1298.R1","volume":"100-b","author":"M Uehara","year":"2018","unstructured":"Uehara M, Takahashi J, Ikegami S, et al. Thoracic aortic aneurysm is an independent factor associated with diffuse idiopathic skeletal hyperostosis. Bone Joint J. 2018;100-b:617\u201321.","journal-title":"Bone Joint J"},{"key":"2278_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1055\/s-0032-1306433","volume":"38","author":"MN Di Minno","year":"2012","unstructured":"Di Minno MN, Iervolino S, Lupoli R, et al. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost. 2012;38:497\u2013505.","journal-title":"Semin Thromb Hemost"},{"key":"2278_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","volume":"102","author":"R Agca","year":"2016","unstructured":"Agca R, Heslinga SC, van Halm VP, Nurmohamed MT. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart. 2016;102:790\u20135.","journal-title":"Heart"},{"key":"2278_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","volume":"30","author":"S Castaneda","year":"2016","unstructured":"Castaneda S, Nurmohamed MT, Gonzalez-Gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2016;30:851\u201369.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2278_CR22","doi-asserted-by":"crossref","unstructured":"Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun. 2017.","DOI":"10.1016\/j.jaut.2017.05.008"},{"key":"2278_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00296-014-3190-0","volume":"35","author":"R Mader","year":"2015","unstructured":"Mader R, Novofastovski I, Iervolino S, et al. Ultrasonography of peripheral entheses in the diagnosis and understanding of diffuse idiopathic skeletal hyperostosis (DISH). Rheumatol Int. 2015;35:493\u20137.","journal-title":"Rheumatol Int"},{"key":"2278_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3899\/jrheum.150162","volume":"43","author":"BG Weiss","year":"2016","unstructured":"Weiss BG, Bachmann LM, Pfirrmann CW, Kissling RO, Zubler V. Whole body magnetic resonance imaging features in diffuse idiopathic skeletal hyperostosis in conjunction with clinical variables to whole body MRI and clinical variables in ankylosing spondylitis. J Rheumatol. 2016;43:335\u201342.","journal-title":"J Rheumatol"},{"key":"2278_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12891-017-1425-4","volume":"18","author":"CC Niu","year":"2017","unstructured":"Niu CC, Lin SS, Yuan LJ, et al. Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord. 2017;18:61.","journal-title":"BMC Musculoskelet Disord"},{"key":"2278_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s10067-017-3617-6","volume":"36","author":"U Arad","year":"2017","unstructured":"Arad U, Elkayam O, Eshed I. Magnetic resonance imaging in diffuse idiopathic skeletal hyperostosis: similarities to axial spondyloarthritis. Clin Rheumatol. 2017;36:1545\u20139.","journal-title":"Clin Rheumatol"},{"key":"2278_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/acr.23244","volume":"70","author":"A Latourte","year":"2018","unstructured":"Latourte A, Charlon S, Etcheto A, et al. Imaging findings suggestive of axial spondyloarthritis in diffuse idiopathic skeletal hyperostosis. Arthritis Care Res (Hoboken). 2018;70:145\u201352.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2278_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14:232\u201344.","journal-title":"Obes Rev"},{"key":"2278_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2019.05.030","volume":"287","author":"SF Ouderk","year":"2019","unstructured":"Ouderk SF, Mohamed Hoesein FAA, Mali WP, Oner FC, Verlaan JJ, et al. Subjects with diffuse idiopathic skeletal hyperostosis have an increased burden of coronary artery disease: an evaluation in the COPDGene cohort. Atherosclerosis. 2019;287:24\u20139.","journal-title":"Atherosclerosis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02278-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02278-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02278-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:14:43Z","timestamp":1629141283000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02278-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02278-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Institutional Review Board (approval numbers, 3960705; 0123-16-EMC). A written informed consent was obtained from all participants in the original cohort.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the results in this article have no personally identifiable information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}